We are live on
!
Find out more
CSIC
Clifford Swan Investment Counsel Portfolio holdings
AUM
$2.94B
1-Year Est. Return
21.31%
This Fund
S&P 500
This Quarter
Est. Return
+21.25%
1 Year Est. Return
+21.31%
3 Year Est. Return
+60.82%
5 Year Est. Return
+91.5%
10 Year Est. Return
+310.89%
AUM
$1.94B
AUM Growth
+$298M
(+18%)
Cap. Flow
-$8.3M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
27.85%
Holding
317
New
17
Increased
75
Reduced
115
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
|
+$4.05M |
| 2 |
Otis Worldwide
OTIS
|
+$3.49M |
| 3 |
Carrier Global
CARR
|
+$2.81M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$2.1M |
| 5 |
AbbVie
ABBV
|
+$1.89M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$4.69M |
| 2 |
RTX Corp
RTX
|
+$4.34M |
| 3 |
PayPal
PYPL
|
+$2.64M |
| 4 |
Apple
AAPL
|
+$2.48M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.08% |
| 2 | Healthcare | 15.36% |
| 3 | Industrials | 13.59% |
| 4 | Consumer Staples | 10.03% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Colgate-Palmolive
CL
$73.6B
| $22.1M | 1.14% |
302,331
-2,837
| -0.9% | -$202K |
|
27
Edwards Lifesciences
EW
$53.6B
| $21.5M | 1.11% |
311,424
-3,024
| -1% | -$215K |
|
28
Amazon
AMZN
$2.88T
| $21.3M | 1.1% |
154,740
-4,600
| -3% | -$556K |
|
29
Wells Fargo
WFC
$269B
| $21.2M | 1.09% |
829,178
+3,464
| +0.4% | +$94.8K |
|
30
HP
HPQ
$26.8B
| $21M | 1.08% |
1,202,692
+15,673
| +1% | +$249K |
|
31
Cisco
CSCO
$488B
| $20.5M | 1.06% |
440,273
+2,762
| +0.6% | +$121K |
|
32
ExxonMobil
XOM
$657B
| $19.5M | 1% |
435,838
+2,929
| +0.7% | +$131K |
|
|
33
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.39B
| $19.2M | 0.99% |
370,595
+78,451
| +27% | +$4.05M |
|
34
McDonald's
MCD
$195B
| $18.6M | 0.96% |
100,773
-3,165
| -3% | -$580K |
|
35
Agilent Technologies
A
$41.9B
| $18M | 0.93% |
203,873
-650
| -0.3% | -$53.3K |
|
36
PepsiCo
PEP
$189B
| $17.1M | 0.88% |
129,565
-1,464
| -1% | -$193K |
|
37
Intuit
INTU
$91.6B
| $16.5M | 0.85% |
55,597
-125
| -0.2% | -$34.3K |
|
38
DuPont de Nemours
DD
$19.5B
| $16.2M | 0.83% |
242,671
-3,815
| -2% | -$223K |
|
39
Boeing
BA
$183B
| $16.1M | 0.83% |
87,809
-11,088
| -11% | -$1.7M |
|
|
DISCK
40
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $15.4M | 0.79% |
800,180
+94,147
| +13% | +$1.84M |
|
41
Pfizer
PFE
$150B
| $15M | 0.77% |
484,043
-6,288
| -1% | -$214K |
|
42
Albemarle
ALB
$15.1B
| $14.8M | 0.76% |
191,544
-7,283
| -4% | -$495K |
|
43
IBM
IBM
$222B
| $13.3M | 0.68% |
115,197
-2,440
| -2% | -$283K |
|
44
Arista Networks
ANET
$265B
| $13.2M | 0.68% |
1,001,744
+38,272
| +4% | +$518K |
|
45
Amgen
AMGN
$225B
| $13.1M | 0.68% |
55,682
-695
| -1% | -$159K |
|
46
Alphabet (Google) Class C
GOOG
$4.19T
| $12.6M | 0.65% |
177,780
+260
| +0.1% | +$17.5K |
|
47
Union Pacific
UNP
$174B
| $12.2M | 0.63% |
72,445
+938
| +1% | +$150K |
|
|
WBA
48
DELISTED
Walgreens Boots Alliance
WBA
| $12.2M | 0.63% |
287,859
+28,862
| +11% | +$1.23M |
|
49
Mondelez International
MDLZ
$79.4B
| $12.1M | 0.62% |
236,368
+2,274
| +1% | +$117K |
|
50
Home Depot
HD
$342B
| $11.9M | 0.61% |
47,493
-100
| -0.2% | -$22.9K |
|
Similar funds
BCF
VGM
MYLI
SCM
CCPM
HCC
NRCM
PHAM
Clifford Swan Investment Counsel's Q2 2020 Portfolio in Review
As of Q2 2020, Clifford Swan Investment Counsel held 317 positions worth $1.94B, up 18% from $1.65B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Clifford Swan Investment Counsel's Q2 2020 filing shows 17 new, 75 increased, 115 reduced and 8 closed positions. Its largest new stake was Otis Worldwide: 67,424 shares worth $3.83M. The largest sale was Allergan plc, an estimated $4.69M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Clifford Swan Investment Counsel's largest Q2 2020 buy was Otis Worldwide: 67,424 shares worth $3.83M.
- Clifford Swan Investment Counsel added most to First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF in Q2 2020, an estimated $4.05M increase.
- Clifford Swan Investment Counsel's biggest Q2 2020 reduction was RTX Corp, cutting an estimated $4.34M.
- Clifford Swan Investment Counsel fully exited Allergan plc in Q2 2020, selling an estimated $4.69M.
- Clifford Swan Investment Counsel's ten largest holdings make up 28% of its $1.94B portfolio in Q2 2020.
- Clifford Swan Investment Counsel opened 17 new positions and closed 8 in Q2 2020.
- Clifford Swan Investment Counsel's portfolio value rose 18% quarter-over-quarter to $1.94B.
Based on Clifford Swan Investment Counsel's 13F filing for Q2 2020, filed 6 Aug 2020.